VP

Vetter Pharma

www.vetter-pharma.com link_icon

Vetter Pharma Company Research Report



Company Overview


  • Name: Vetter Pharma

  • Mission: To combine tradition and innovation to reliably supply patients worldwide with medicines from state-of-the-art production sites.

  • Founded: 1950 by Helmut Vetter

  • Key People: Martin Schwab (Vice President Vetter Development Services Rankweil), Susanne Lemaine (Vice President & Head of Site at Vetter Development Services Chicago)

  • Headquarters: Ravensburg, Baden-Württemberg, Germany

  • Number of Employees: 6,600+ worldwide

  • Revenue: Over 1 billion euros in 2023 from specialized aseptic filling services

  • Known For: Vetter Pharma is known for its aseptic manufacturing of injectable medicines and as a leading pharmaceutical service provider (CDMO).


Products and Services


  • Products Offered:

  • Drug Product Development: Providing scalability, quality, and sustainability for product profiles.

  • Aseptic Filling & Visual Inspection: Covering the spectrum from clinical manufacturing to commercial-scale filling.

  • Device Assembly & Packaging: Offering secondary packaging and injection device options.

  • Analytical Services: Rigorously evaluating product quality throughout the manufacturing process.

  • Regulatory Support: Managing product compliance from clinical development through market authorization.

  • Logistic Services: Supporting logistics from API storage to a ready-to-dispatch product.


  • High-level Description and Key Features:

  • Vetter Pharma offers comprehensive fill-and-finish services covering various products and production phases. They utilize high-quality standards and innovative technologies for aseptic filling, which includes syringes, cartridges, and vials.


Recent Developments


  • Recent Developments:

  • New Products/Features:

  • Automated tube palletizer recognized with ISPE Robotics Application of the Year Award in the "Packaging & Final Assembly" category.

  • Recent Achievements:

  • Achieved CO2 neutrality of all sites in 2021.

  • Numerous accolades such as Best Managed Companies Award 2024, CDMO Leadership Awards, and EcoVadis Platinum Medal in 2023.

  • New Partnerships and Expansions:

  • New site in Rankweil, Austria, became operational in 2022.

  • Expanded presence in international markets, including new site operations in Rankweil, Austria.


Awards and Recognition


  • Awards:

  • ISPE Facility of the Year Award – Various categories including "Facility of the Future"

  • EcoVadis Gold and Platinum Medals for sustainability performance

  • CDMO Leadership Awards in multiple categories

  • Frost & Sullivan Global Customer Value Leadership Award


Summary


Vetter Pharma stands as a robust and innovative pharmaceutical service provider specializing in aseptic filling and injectable medicines. With over 70 years of experience, the family-owned company has made significant contributions to the biopharmaceutical industry by adhering to high-quality standards and sustainable practices. Vetter operates globally, providing comprehensive services that cover the entire spectrum of drug development and manufacturing, with a focus on sustainability and innovation. The company's strategic expansions and partnerships reflect its commitment to growth and excellence in delivering essential medicines worldwide.